S. Ocran

Construction of yellow fever/St. Louis encephalitis chimeric virus and the use of chimeras as a diagnostic tool.

J. Roehrig, R. Lanciotti, F. Guirakhoo, 2004, The American journal of tropical medicine and hygiene.

Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil.

F. Guirakhoo, T. Monath, R. Marchevsky, 2001, Virology.

Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates.

F. Guirakhoo, T. Monath, K. Draper, 2002, Virology.

High Fidelity of Yellow Fever Virus RNA Polymerase

F. Guirakhoo, T. Monath, S. Pougatcheva, 2004, Journal of Virology.

Construction, Safety, and Immunogenicity in Nonhuman Primates of a Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine

F. Guirakhoo, T. Monath, K. Soike, 2001, Journal of Virology.

Safety and Efficacy of Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Formulations in Nonhuman Primates

F. Guirakhoo, T. Monath, J. Lang, 2004, Journal of Virology.

Construction and biological characterization of artificial recombinants between a wild type flavivirus (Kunjin) and a live chimeric flavivirus vaccine (ChimeriVax-JE).

F. Guirakhoo, T. Monath, A. Rumyantsev, 2007, Vaccine.

Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencing.

F. Guirakhoo, T. Monath, K. Pugachev, 2002, Vaccine.